Member Info for occams

Not us

https://www.bloomberg.com/news/articles/2020-06-15/covid-test-maker-sued-by-investor-over-100-accurate-claim

Use an adblocker

https://alumni.nottingham.ac.uk/a/covid-19-emergency-appeal

https://www.marketscreener.com/FUSION-ANTIBODIES-PLC-39051284/news/Fusion-Antibodies-partner-with-A-Frontier-to-deliver-services-to-South-Korea-30744841/
Some news should have been RNS'ed

https://www.theguardian.com/world/2020/may/29/india-mumbai-hospitals-overwhelmed-coronavirus-cases

Patients share beds. Sign of a wealthy country

https://www.theguardian.com/world/2020/jun/09/anthony-fauci-coronavirus-pandemic-far-from-over

Themarketseer is obviously an American, wouldn't be surprised if he was part of this stunt

Up to $1.46 after hours, approx 23p

Maybe just an American way of doing business

Is this the one

https://www.lse.co.uk/rns/MTPH/midatech-signs-global-agreement-for-panobinostat-jks2zb8z7zbkbmg.html

Approx 22p, if i can buy sub 20p will average down, assuming no more news

You replied to that post by saying,

You mention that “their top priority/most valuable asset isn't even theirs.” Well, none of the drugs Midatech develop are theirs. That is the whole point of Midatech – they use their three technologies (which they do own) to make already approved drugs perform better. MTX110 is panobinostat (Farydak) – developed by Novartis. In March 2019, Secure Bio obtained global commercialisation rights for Farydak from Novartis to treat patients with multiple myeloma, the only indication for which it is approved. In June 2017, Midatech signed a global license agreement with Novartis to investigate panobinostat for treatment of brain cancers. MTX110 received orphan designation for DIPG in October 2019.

Your letter was directed to persons who are no longer working at Midatech.

Currently $1.37, approx 22p

Date on the letter refers to the original agreement, i think

What a day, first thing this morning ODX and now this!

https://www.investegate.co.uk/midatech-pharma-plc--mtph-/rns/purported-termination-of-mtx110-licence-agreement/202006091604494434P/

What kind of name is that

UT: Uncrossing Trade - This is used for for the single uncrossing trade detailing the total executed volume and uncrossing price as a result of a SETS auction. It's a trade between MM's to balance their books.
I won't say anything further!!!

Sent an email to MTPH regarding the message below and asking for any news to lift the SP
to be RNS'ed.